Alnylam Pharmaceuticals
ALNY
#661
Rank
โ‚น2.571 T
Marketcap
โ‚น19,934
Share price
-8.44%
Change (1 day)
41.32%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company